EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Top Buys
| 1 |
Futu Holdings
FUTU
|
$31.5M |
| 2 |
Applied Materials
AMAT
|
$29.1M |
| 3 |
Apple
AAPL
|
$15.5M |
| 4 |
Microsoft
MSFT
|
$12.6M |
| 5 |
NVIDIA
NVDA
|
$11.6M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$28.5M |
| 2 |
TSMC
TSM
|
$15.1M |
| 3 |
KE Holdings
BEKE
|
$11.9M |
| 4 |
ASE Group
ASX
|
$7.99M |
| 5 |
Yum China
YUMC
|
$5.17M |
Sector Composition
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Gartner
IT
$18.6B
| $500K | 0.03% |
1,114
+252
| +29% | +$113K |
|
177
Monster Beverage
MNST
$61B
| $499K | 0.03% |
9,995
+199
| +2% | +$9.94K |
|
178
Ross Stores
ROST
$49.4B
| $490K | 0.03% |
3,375
+50
| +2% | +$7.27K |
|
179
Ionis Pharmaceuticals
IONS
$9.76B
| $489K | 0.03% |
10,255
+430
| +4% | +$20.5K |
|
180
Super Micro Computer
SMCI
$24B
| $477K | 0.03% |
5,820
+1,760
| +43% | +$144K |
|
181
Exelixis
EXEL
$10.2B
| $477K | 0.03% |
21,217
+1,705
| +9% | +$38.3K |
|
182
Krystal Biotech
KRYS
$4.35B
| $466K | 0.03% |
2,539
+17
| +0.7% | +$3.12K |
|
183
American Electric Power
AEP
$57.8B
| $464K | 0.03% |
5,286
+105
| +2% | +$9.21K |
|
184
Monolithic Power Systems
MPWR
$41.5B
| $462K | 0.03% |
562
+166
| +42% | +$136K |
|
185
Insmed
INSM
$30.7B
| $457K | 0.03% |
6,815
-8,762
| -56% | -$587K |
|
|
CERE
186
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $455K | 0.03% |
11,132
+626
| +6% | +$25.6K |
|
187
Keurig Dr Pepper
KDP
$38.9B
| $438K | 0.02% |
13,125
-20
| -0.2% | -$668 |
|
188
Revolution Medicines
RVMD
$7.57B
| $438K | 0.02% |
11,274
-2,164
| -16% | -$84K |
|
189
Vaxcyte
PCVX
$4.29B
| $434K | 0.02% |
5,751
-211
| -4% | -$15.9K |
|
190
Fair Isaac
FICO
$36.8B
| $429K | 0.02% |
288
+83
| +40% | +$124K |
|
191
Diamondback Energy
FANG
$40.2B
| $428K | 0.02% |
2,140
+134
| +7% | +$26.8K |
|
192
Alkermes
ALKS
$4.94B
| $422K | 0.02% |
17,520
+2,704
| +18% | +$65.2K |
|
193
Paychex
PAYX
$48.7B
| $421K | 0.02% |
3,549
+54
| +2% | +$6.4K |
|
194
BridgeBio Pharma
BBIO
$10.2B
| $418K | 0.02% |
16,496
+1,785
| +12% | +$45.2K |
|
195
Halozyme
HALO
$8.76B
| $416K | 0.02% |
7,954
-2,431
| -23% | -$127K |
|
196
Biohaven
BHVN
$1.68B
| $412K | 0.02% |
11,883
+4,407
| +59% | +$153K |
|
197
Charter Communications
CHTR
$35.7B
| $409K | 0.02% |
1,367
+16
| +1% | +$4.78K |
|
198
Workday
WDAY
$61.7B
| $405K | 0.02% |
1,812
+64
| +4% | +$14.3K |
|
199
Thomson Reuters
TRI
$78.7B
| $396K | 0.02% |
2,349
-1,452
| -38% | -$245K |
|
200
AstraZeneca
AZN
$253B
| $388K | 0.02% |
4,978
+107
| +2% | +$8.35K |
|